Aberrant expression of epidermal growth factor receptor and its interaction with protein kinase C δ in inflammation associated neoplastic transformation of human esophageal epithelium in high risk populations

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 2, 2011, Pages 382-390

  Parthasarathy, Seshacharyulu ^a   Dhayaparan, Devaraj ^a   Jayanthi, Venkatraman ^c   Devaraj, Sivasitambaram Niranjali ^b   Devaraj, Halagowder ^a  

^a Unit of Biochemistry   (India)

^b UNIVERSITY OF MADRAS   (India)

^c STANLEY MEDICAL COLLEGE   (India)

Author keywords

Dysplasia; Epidermal growth factor receptor; Protein kinase C ; Squamous cell carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C DELTA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CONTROLLED STUDY; DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SMOKING; SQUAMOUS CELL CARCINOMA;

EID: 78851472411     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06526.x     Document Type: Article

References (38)

1. Parkin DM. International variation. Oncogene 2004; 23: 6329-40.
2. Castellsague X, Munoz N, De Stefani E etal. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int. J. Cancer 1999; 82: 657-64.
3. Gajalakshmi V, Swaminathan R, Shanta V. An independent survey to assess completeness of registration: population based cancer registry, Chennai, India. Asian Pac. J. Cancer Prev. 2001; 2: 179-83.
4. Reinmuth N, Meister M, Muley T etal. Molecular determinants of response to RTK-targeting agents in non-small cell lung cancer. Int. J. Cancer 2006; 119: 727-34.
5. Pawson T, Nash P. Protein-protein interactions define specificity in signal transduction. Genes Dev. 2000; 14: 1027-47.
6. Denning MF, Dlugosz AA, Threadgill DW, Magnuson T, Yuspa SH. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C-δ. J. Biol. Chem. 1996; 271: 5325-31.
7. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007; 26: 3291-310.
8. Caunt CJ, Rivers CA, Conway-Campbell BL, Norman MR, McArdle CA. Epidermal growth factor receptor and protein kinase C signaling to ERK2: spatiotemporal regulation of ERK2 by dual specificity phosphatases. J. Biol. Chem. 2008; 283: 6241-52.
9. Webb CP, Van Aelst L, Wigler MH, Woude GF. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc. Natl. Acad. Sci. USA 1998; 95: 8773-8.
10. Keswani RN, Chumsangsri A, Mustafi R, Delgado J, Cohen EE, Bissonnette M. Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line. Dis. Esophagus. 2008; 21: 514-21.
11. Adams JL, Badger AM, Kumar S, Lee JC. p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. Prog. Med. Chem. 2001; 38: 1-60.
12. Pearson G, Robinson F, Gibson TB etal. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 2001; 22: 153-83.
13. Jaiswal K, Lopez GC, Souza RF, Spechler SJ, Sarosi GA Jr. Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line. Am. J. Physiol. Gastrointest. Liver Physiol. 2006; 290: 335-42.
14. Tremblay PL, Auger FA, Huot J. Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene 2006; 25: 6563-73.
15. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-7.
16. Schmitz H, Fromm M, Bentzel CJ etal. Tumor necrosis factor-alpha (TNF-α) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J. Cell Sci. 1999; 112: 137-46.
17. Tselepis C, Perry I, Dawson C etal. Tumour necrosis factor-α in Barrett's oesophagus: a potential novel mechanism of action. Oncogene 2002; 21: 6071-81.
18. Collart MA, Baeuerle P, Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol. Cell Biol. 1990; 10: 1498-506.
19. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 2004; 4: 540-50.
20. Izzo JG, Malhotra U, Wu TT etal. Association of activated transcription factor nuclear factor κB with chemoradiation resistance and poor outcome in esophageal carcinoma. J. Clin. Oncol. 2006; 24: 748-54.
21. Dawsey SM, Lewin KJ, Liu FS, Wang GQ, Shen Q. Esophageal morphology from Linxian, China: squamous histological findings in 754 subjects. Cancer 1994; 73: 2027-37.
22. Qichun W, Lirong C, Liming S, Hans N, Kenneth W, Jörgen C. EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases. Int. J. Oncol. 2007; 31: 493-9.
23. Takayamal T, Shiozakil H, Doki Y etal. Aberrant expression and phosphorylation of β-catenin in human colorectal cancer. Br. J. Cancer 1996; 77: 605-13.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J. Biol. Chem. 1951; 193: 265-75.
25. Udayakumar G, Jayanthi V, Devaraj N, Devaraj H. Interaction of MUC1 with β-catenin modulates the WNT target gene cyclin D1 in H. pylori- induced gastric cancer. Mol. Carcinog. 2007; 46: 807-17.
26. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979; 76: 4350-4.
27. Znaor A, Brennan P, Gajalakshmi V. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int. J. Cancer 2003; 105: 681-6.
28. Higashiyama S, Iwabuki H, Morimoto C etal. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci. 2008; 99: 214-20.
29. Tari AM, Hung MC, Li K, Lopez-Berestein G. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. Oncogene 1999; 18: 1325-32.
30. Ohsaki Y, Tanno S, Fujita Y etal. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncol. Res. 2000; 7: 603-7.
31. Hanawa M, Suzuki S, Dobashi Y etal. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus. Int. J. Cancer 2006; 118: 1173-80.
32. Ozawa S, Ueda M, Ando N etal. High incidence of EGF receptor hyperproduction in esophageal squamous-cell carcinomas. Int. J. Cancer 2006; 39: 333-37.
33. Kannangai R, Sahin F, Torbenson MS. EGFR is phosphorylated at Ty845 in hepatocellular carcinoma. Mod. Pathol. 2006; 19: 1456-61.
34. Miyawaki M, Hijiya N, Tsukamoto Y etal. Enhanced phosphorylation of the epidermal growth factor receptor at the site of tyrosine 992 in esophageal carcinomas. APMIS 2008; 116: 1097-106.
35. 2-treated cells and its activation by tyrosine kinase in vitro. Proc. Natl. Acad. Sci. USA 2001; 98: 6587-92.
36. 2 stimulated cells. J. Biochem. 2008; 143: 31-8.
37. Ravichandran KS. Signaling via Shc family adapter proteins. Oncogene 2001; 20: 6322-30.
38. 2 cells via the epidermal growth factor receptor signaling pathway. J. Biol. Chem. 2000; 275: 9222-9.